Three startups – two helping to make a green economy and one creating next-generation microbial images – graduated Nov. 16 from Cornell’s Center for Life Science Ventures business incubator.
The Cornell Board of Trustees and Weill Cornell Medicine Board of Fellows have approved the appointment of Dr. Francis Lee as interim dean of Weill Cornell Medicine and interim provost for medical affairs.
New research offers insight as to why individuals who inherit a mutation in one copy of the BRCA1 gene often develop mutations in their remaining normal copy of the BRCA1 gene, setting the stage for tumors to develop.
A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA vaccines to deter cancer development in at-risk groups.
The long delays some COVID patients experience in regaining consciousness after ventilation may protect the brain from oxygen deprivation, new research shows.
With the six-month, $1 million grant, Weill Cornell Medicine researchers will assess how countries have been monitoring and reporting COVID-19 infections and outcomes.
The study suggests that a unique set of regulatory networks controlled by neurons in the gut may be viable targets for future drug therapies to combat chronic inflammatory diseases including asthma, allergy and inflammatory bowel disease.
The study found that dietary inulin fiber alters the metabolism of certain gut bacteria, which in turn triggers what scientists call type 2 inflammation in the gut and lungs.
